Internationally renowned neuroscientist Yasmin Hurd’s ground-breaking cannabidiol studies are leading the development of potential treatment for opioid addiction and other disorders. She uses multidisciplinary research approaches to highlight the complex neurobiological mechanisms underlying addiction vulnerability. Her work includes the study of epigenetic disturbances as key contributions to the long-term impact of drugs on both the brain and behavior enhancing psychiatric vulnerability. Her work studying the human brain and complementary translational animal models flourishes at the intersection of molecular biology, behavioral neuropharmacology, neuroimaging, and genetics. At the Icahn School of Medicine in New York, Yasmin is a Professor of Psychiatry, Neuroscience and Pharmacological Sciences and the Ward-Coleman Chair in Translational Neuroscience. Yasmin directs the Addiction Institute in the Mount Sinai Behavioral Health System, covering one of the largest addiction populations in the US. Yasmin is a National Academy of Medicine inductee.Find out more
The opioid epidemic is one of the biggest and most costly health risks facing modern America. Yet, CBD Scientist Yasmin Hurd suggests that there is a way to overcome this epidemic. Yasmin’s research focuses on Cannabidiol (CBD) as a non-addictive, efficacious treatment option for overcoming opioid addiction. From scientific research to the history behind Cannabinoids, Yasmin shares how the unique characteristics of CBD could have meaningful impacts. Specifically, she shares how Cannabinoids affect chemicals in the brain which regulate anxiety and emotion. As such, in a large NIH-funded clinical trial with CBD, Yasmin is investigating CBD-based solutions in people with opioid use disorder.
Yasmin envisions a future in which CBD treatments can help individuals overcome opioid addiction to eradicate the opioid epidemic. Watch Yasmin’s TEDMED 2020 Talk, "Could CBD help opioid users overcome addiction?"